6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trialJoo‐Yong Hahn, Seung‐Ho Hur, Seung‐Woon Rha et al.|The Lancet|2018Cited by 372
Effect of Paclitaxel‐Eluting Versus Sirolimus‐Eluting Stents on Coronary Restenosis in Korean Diabetic PatientsMoo Hyun Kim, DO‐SUN LIM, Soon Jun Hong et al.|Journal of Interventional Cardiology|2008Cited by 27
Effectiveness and Safety of Zotarolimus-Eluting Stent (Resolute™ Integrity) in Patients with Diffuse Long Coronary Artery DiseaseKeun Ho Park, Doo‐Il Kim, Youngkeun Ahn et al.|Korean Circulation Journal|2019Cited by 23
Comparison of three‐year clinical outcomes between sirolimus‐versus paclitaxel‐eluting stents in diabetic patients: Prospective randomized multicenter trialSoon Jun Hong, Do‐Sun Lim, Moo Hyun Kim et al.|Catheterization and Cardiovascular Interventions|2009Cited by 14
Dual Antiplatelet Therapy De-Escalation in Stabilized Myocardial Infarction With High Ischemic RiskMyunhee Lee, Jang Hoon Lee, Sungwook Byun et al.|JAMA Cardiology|2023Cited by 10